Does TRPM6 rs3750425 affect magnesium handling and serum magnesium status?

The TRPM6 ion channel is a primary gatekeeper of systemic magnesium homeostasis, orchestrating both active absorption in the intestine and reabsorption in the renal tubules. Genetic variations in this channel can directly influence individual magnesium status and metabolic health.

Mechanistic insights

• The TRPM6 gene encodes a key magnesium-permeable ion channel. The rs3750425 single nucleotide polymorphism (SNP) is a non-synonymous coding variant that results in a Val1393Ile amino acid substitution.
• This structural alteration in the TRPM6 channel is associated with compromised channel function and altered biophysical activity, directly affecting how the body transports and retains magnesium.

Clinical and systemic effects

• Alterations in TRPM6-mediated transport directly shift systemic magnesium handling, modulating overall serum levels.
• Clinical cohort data show that individuals carrying the GG (Val/Val) genotype of rs3750425 exhibit significantly lower serum magnesium levels compared to those with GA and AA genotypes.
• This genetic variation exhibits a strong gene-diet interaction. When dietary magnesium intake is low, carriers of this variant (especially in combination with other TRPM6 polymorphisms) have a sharply elevated risk of developing metabolic complications, including type 2 diabetes and gestational diabetes.

Bottom line

• The TRPM6 rs3750425 polymorphism (Val1393Ile) is a functional variant that influences systemic magnesium status; individuals with the GG genotype have lower serum magnesium levels and a higher vulnerability to metabolic complications under conditions of low dietary magnesium intake.